Tumor-specific adenoviral gene therapy: transcriptional repression of gene expression by utilizing p53-signal

Florian Kühnel1, Lars Zender, Thomas Wirth

  • 1Department of Gastroenterology, Hepatology and Endocrinology, Medical School Hannover, Carl Neuberg Str. 1, 30625 Hannover, Germany.

Cancer Gene Therapy
|December 19, 2003
PubMed

Insights

This study developed a tumor-specific gene therapy using adenoviral vectors. It leverages p53 pathway activation to control gene expression, achieving over 99% repression in normal cells for enhanced safety.

Area of Science:

  • Oncolytic Virotherapy
  • Molecular Biology
  • Gene Therapy

Background:

  • p53 tumor suppressor protein plays a critical role in cellular response to DNA damage.
  • Adenoviral vectors are widely used in gene therapy but lack tumor specificity.
  • Targeted gene expression is crucial for effective and safe cancer gene therapy.

Purpose of the Study:

  • To develop a novel adenoviral gene therapy strategy for tumor-specific gene expression.
  • To identify effective transcriptional repressors for controlling gene expression in a p53-dependent manner.
  • To enhance tumor selectivity of adenoviral vectors by utilizing the p53 pathway.

Main Methods:

  • Construction of CMV-driven adenoviral vectors (CMVgal) with GAL4-binding sites.
  • Investigation of 11 GAL4-DNA binding domain (DBD) fusion proteins for transcriptional repression.
  • Utilizing a p53-dependent promoter to control the expression of the GAL4-KRAB-A repressor.
  • Employing double-recombinant adenoviral vectors (Ad-RGCdR) for gene delivery.

Main Results:

  • GAL4-KRAB-A demonstrated potent repression of CMVgal activity in p53 wild-type cells.
  • Adenoviral vector Ad-RGCdR showed p53-dependent gene expression, higher in p53 mutant cells.
  • Preactivation of p53 signaling via chemotherapy enhanced repression in wild-type cells (>99%).
  • Achieved significant tumor-specific gene expression control by leveraging p53 signaling.

Conclusions:

  • Controlled gene expression via transcriptional repression is a viable strategy for tumor-specific adenoviral gene therapy.
  • The p53 pathway can be effectively utilized to enhance the safety and specificity of adenoviral gene therapy.
  • The developed Ad-RGCdR vector with GAL4-KRAB-A offers a promising tool for targeting cancers with functional p53 signaling.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Gene Therapy01:22

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...